Recommended Pages at medcitynews.com
Parkinson’s disease monitoring technology awarded new patent
medcitynews.com — “Read about technology that can remotely monitor the severity of Parkinson's disease patients at home.” View full resource at medcitynews.com
Most Recently Shared on June 5, 2012 at 8:10 pm By:
Scott Strumello Patient Expert
Parkinson’s disease monitoring technology awarded new patent http://t.co/2odXgtfA via @MedCityNews
Athersys, University Hospitals partner for clinical trials of MultiStem for stroke
medcitynews.com — “Athersys (NASDAQ:ATHX), which is developing stem cell treatments, will work with University Hospitals Cleveland on a phase 2 clinical trial for ischemic stroke.” View full resource at medcitynews.com
Most Recently Shared on February 23, 2012 at 3:40 pm By:
RT @medcitynews: Athersys, University Hospitals partner for clinical trials of MultiStem for stroke http://t.co/1PbHc1ee
Glaucoma treatment pharma company Aerie closes $41M venture round
medcitynews.com — “Glaucoma treatment company Aerie Pharmaceuticals has closed a $41.3 million round of financing as the company prepares for phase III trials. Aerie--™s glaucoma treatment candidate is AR-12286. The compound is what--™s called a Rho-kinase inhibitor. Aerie has said AR-12286--™s mechanism of action repairs the diseased tissue, restoring normal function to the eye. No glaucoma medicines currently available are Rho-kinase inhibitors. During the recent CED Biotech/Life Science confer” View full resource at medcitynews.com
Most Recently Shared on March 3, 2011 at 12:48 am By:
Glaucoma treatment pharma company Aerie closes $41M venture round http://bit.ly/g6Px07
